Results 91 to 100 of about 517,509 (243)

Concomitant acute interstitial nephritis and autoimmune hemolytic anemia induced by omeprazole

open access: yesClinical Case Reports, 2020
Proton pump inhibitors (PPI)—induced acute interstitial nephritis and autoimmune hemolytic anemia can occur concomitantly, which should prompt discontinuation of PPI. PPI should wisely be prescribed and discontinued when no longer needed.
Neetu Sharma, Randy Ip, Tarik Hadid
doaj   +1 more source

Autoimmune hemolytic anemia in a patient with mycosis fungoides

open access: yes, 1990
We report a case of autoimmune hemolytic anemia in a patient with mycosis fungoides. We propose that autoimmune hemolytic anemia may be induced by cutaneous lymphoproliferative diseases.
JP Knox   +5 more
core  

Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia is associated with IgVH status

open access: yes, 2010
Anemia, Hemolytic, Autoimmune; Databases, Factual; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Leukemia, Lymphocytic, Chronic, B ...
Giaretta, Ilaria   +5 more
core   +1 more source

Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang   +16 more
wiley   +1 more source

Tuberculosis and autoimmune hemolytic anemia: Case report and literature review

open access: yes, 2014
Tuberculosis (TB) is a mycobacterial infectious disease that can affect any organ system. The wide varieties of manifestations that TB can present with make the disease a challenge for treating physicians. Anemia is commonly seen in patients with TB, and
Mohammed Almahmeed   +2 more
core   +1 more source

Clinical Features and Predictors of Hospital Stay in Paediatric Epstein–Barr Virus Infectious Mononucleosis: A Multicentre Cohort Study

open access: yesActa Paediatrica, Volume 115, Issue 12, Page 2880-2887, December 2026.
ABSTRACT Aim To describe age‐specific clinical features and identify predictors of length of hospital stay in children and adolescents with primary Epstein–Barr virus (EBV) infectious mononucleosis (IM). Methods This multicentre retrospective cohort study included all children and adolescents aged 0–17 years with a verified primary EBV infection in the
Lasse H. Nyhegn   +5 more
wiley   +1 more source

Autoimmune hemolytic anemia in patients with systemic lupus erythematosus

open access: yes, 2000
PURPOSE: We sought to evaluate the clinical and serologic associations with, and outcomes of, autoimmune hemolytic anemia, as compared with other types of anemia, in patients with systemic lupus erythematosus (SLE).
Ioannidis, J. P.   +4 more
core   +2 more sources

Autoimmune hemolytic anemia as an initial manifestation of Hodgkin’s Disease: Case report [PDF]

open access: yes, 2016
This paper presents the case of an 11 year-old male who attended the Internal Medicine Service at a high complexity pediatric hospital. Initially, the patient attended due to a clinical profile consisting of autoimmune hemolytic anemia that was partially
Urrego-Díaz, José Augusto   +7 more
core   +1 more source

Clonal Dynamics of GPI‐Deficient Cells in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): A Retrospective Follow‐Up Analysis

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1583-1592, December 2026.
ABSTRACT This retrospective, single‐center study aimed to characterize clonal dynamics of GPI‐deficient cells in patients with paroxysmal nocturnal hemoglobinuria (PNH) or PNH/aplastic anemia (AA) syndrome using multiparameter flow cytometry including FLAER.
Sandra M. Frey   +6 more
wiley   +1 more source

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis

open access: yesİstanbul Kuzey Klinikleri, 2018
Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions,
Fazia A. Mir   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy